Original Research

Published on 16 Jan 2024

Development and validation of a structured questionnaire for assessing risk factors of medication non-adherence among pulmonary tuberculosis patients in Indonesia

in Drugs Outcomes Research and Policies

Leonov Rianto
Ika Agustina
Sofa D. Alfian
Aulia Iskandarsyah
Ivan Surya Pradipta
Rizky Abdulah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1257353

2,466 views

Perspective

Published on 12 Jan 2024

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

in Drugs Outcomes Research and Policies

Ravinder Claire
Jamie Elvidge
Shahid Hanif
Hannah Goovaerts
Peter R. Rijnbeek
Páll Jónsson
Karen Facey
Dalia Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1289365

3,562 views
6 citations

Original Research

Published on 11 Jan 2024

Comparative price analysis of biological medicines: disparities generated by different pricing policies

in Drugs Outcomes Research and Policies

Marcela Amaral Pontes
Alane Andrelino Ribeiro
Flávia Caixeta Albuquerque
Silvana Nair Leite Cotenzini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256542

2,075 views
2 citations

Original Research

Published on 11 Jan 2024

Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

in Drugs Outcomes Research and Policies

Cristina Andrés-Iglesias
Ivan Fernandez-Bueno
Salvador Pastor-Idoate
Rosa M. Coco-Martin
J. Carlos Pastor

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1310463

2,743 views

Original Research

Published on 11 Jan 2024

Impact of early heparin therapy on mortality in critically ill patients with sepsis associated acute kidney injury: a retrospective study from the MIMIC-IV database

in Drugs Outcomes Research and Policies

Zhi-Peng Zhou
Li Zhong
Yan Liu
Zhen-Jia Yang
Jia-Jia Huang
Da-Zheng Li
Yu-Hua Chen
Ying-Yi Luan
Yong-Ming Yao
Ming Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261305

2,682 views

Original Research

Published on 09 Jan 2024

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer

in Drugs Outcomes Research and Policies

Huina Wu
Lei Sun
Rui Feng
Huiyue Zhang
Ke Tang
Shuo Wang
Jing Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1269129

1,455 views

Correction

Published on 09 Jan 2024

Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

in Drugs Outcomes Research and Policies

Ratul Bhowmik
Ravi Kant
Ajay Manaithiya
Daman Saluja
Bharti Vyas
Ranajit Nath
Kamal A. Qureshi
Seppo Parkkila
Ashok Aspatwar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1340724

735 views

Original Research

Published on 08 Jan 2024

Bridging the new drug access gap between China and the United States and its related policies

in Drugs Outcomes Research and Policies

Xingyue Zhu
Yang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1296737

3,310 views
2 citations

Original Research

Published on 08 Jan 2024

Drug compatibility with various closed intravenous infusion containers

in Drugs Outcomes Research and Policies

Chang-yu Zhu
Hui-ying Zuo
Hong-lin Li
Rong-sheng Tong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265945

2,947 views
1 citation

Curriculum, Instruction, and Pedagogy

Published on 08 Jan 2024

Supporting clinical research professionals through educational innovations

in Drugs Outcomes Research and Policies

Diana Lee-Chavarria
Tammy L. Loucks
Rechelle Paranal
Royce Sampson
Carol Feghali-Bostwick

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1304415

1,448 views
1 citation

Original Research

Published on 08 Jan 2024

Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome

in Drugs Outcomes Research and Policies

Masanari Kuwabara
Michikazu Nakai
Yoko Sumita
Yoshitaka Iwanaga
Ryusuke Ae
Takahide Kodama
Ichiro Hisatome
Naoyuki Kamatani

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1289386

2,043 views
1 citation

Systematic Review

Published on 08 Jan 2024

Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials

in Drugs Outcomes Research and Policies

Xingyue Zheng
Li Nong
Yujie Song
Lizhu Han
Yuan Zhang
Qinan Yin
Yuan Bian

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1326224

3,545 views
2 citations

Systematic Review

Published on 03 Jan 2024

Nanomedicine drug delivery in South Africa: a retrospective study on research, funding and collaboration

in Drugs Outcomes Research and Policies

Faatiema Salie
Trust Saidi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1317137

1,809 views

Systematic Review

Published on 22 Dec 2023

The current view of potentially inappropriate medications (PIMs) among older adults in Saudi Arabia: a systematic review

in Drugs Outcomes Research and Policies

Fawaz M. Alotaibi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1325871

2,232 views
1 citation

Original Research

Published on 21 Dec 2023

Reimagining the joint task force core competency framework for rural and frontier clinical research professionals conducting hybrid and decentralized trials

in Drugs Outcomes Research and Policies

Jamie M. Besel
Elizabeth A. Johnson
Jiahui Ma
Becky Kiesow

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1309073

1,851 views
1 citation

Systematic Review

Published on 14 Dec 2023

Efficacy and safety profile of elexacaftor-tezacaftor-ivacaftor triple therapy on cystic fibrosis: a systematic review and single arm meta-analysis

in Drugs Outcomes Research and Policies

Wenye Xu
Ting Wu
Zijing Zhou
Zhihong Zuo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1275470

2,514 views
4 citations

Navigation group

Articles

Development and validation of a structured questionnaire for assessing risk factors of medication non-adherence among pulmonary tuberculosis patients in Indonesia

Advancing the use of real world evidence in health technology assessment: insights from a multi-stakeholder workshop

Comparative price analysis of biological medicines: disparities generated by different pricing policies

Ala®sil chemical characterization and toxicity evaluation: an example of the need for the Medical Device Regulation 2017/745

Impact of early heparin therapy on mortality in critically ill patients with sepsis associated acute kidney injury: a retrospective study from the MIMIC-IV database

Cost-effectiveness of rezvilutamide versus bicalutamide and androgen-deprivation therapy in patients with highvolume, metastatic, hormone-sensitive prostate cancer

Corrigendum: Navigating bioactivity space in anti-tubercular drug discovery through the deployment of advanced machine learning models and cheminformatics tools: a molecular modeling based retrospective study

Bridging the new drug access gap between China and the United States and its related policies

Drug compatibility with various closed intravenous infusion containers

Supporting clinical research professionals through educational innovations

Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome

Comparison of efficacy and safety between aspirin and oral anticoagulants for venous thromboembolism prophylaxis after major orthopaedic surgery: a meta-analysis of randomized clinical trials

Nanomedicine drug delivery in South Africa: a retrospective study on research, funding and collaboration

The current view of potentially inappropriate medications (PIMs) among older adults in Saudi Arabia: a systematic review

Reimagining the joint task force core competency framework for rural and frontier clinical research professionals conducting hybrid and decentralized trials

Efficacy and safety profile of elexacaftor-tezacaftor-ivacaftor triple therapy on cystic fibrosis: a systematic review and single arm meta-analysis